(ENZY) Enzymatica publ - Performance 12.8% in 12m
ENZY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-60.29%
#132 in Peer-Group
Rel. Strength
58.10%
#3217 in Stock-Universe
Total Return 12m
12.79%
#61 in Peer-Group
Total Return 5y
-82.30%
#144 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 66.7 |
| High / Low | SEK |
|---|---|
| 52 Week High | 4.90 SEK |
| 52 Week Low | 1.36 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 76.26 |
| Buy/Sell Signal +-5 | -1.15 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ENZY (12.8%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ENZY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ENZY
| Total Return (including Dividends) | ENZY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -3.96% | 0.95% | 4.08% |
| 3 Months | -7.62% | 1.54% | 19.65% |
| 12 Months | 12.79% | -5.25% | 12.88% |
| 5 Years | -82.30% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | ENZY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -25.8% | 24.8% | 86.9% |
| 3 Months | -81.5% | -21.1% | 97.2% |
| 12 Months | 40.7% | -78.2% | 46% |
| 5 Years | -89.4% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th25.50 | -4.87% | -7.72% |
| 3 Month | %th10.50 | -9.02% | -22.79% |
| 12 Month | %th70.00 | 19.04% | -0.08% |
| 5 Years | %th26.50 | -87.85% | -91.71% |
FAQs
Does Enzymatica publ (ENZY) outperform the market?
Yes,
over the last 12 months ENZY made 12.79%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months ENZY made -7.62%, while XLV made 1.54%.
Performance Comparison ENZY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ENZY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.8% | -8% | 58.8% | -0% |
| US NASDAQ 100 | QQQ | -0.5% | -8.1% | 57.4% | 2% |
| German DAX 40 | DAX | -2.9% | -5.8% | 46.7% | -19% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.2% | -9.2% | 54.5% | -8% |
| Hongkong Hang Seng | HSI | 0.5% | -6.4% | 38.6% | -24% |
| India NIFTY 50 | INDA | 0.3% | -4% | 59.3% | 15% |
| Brasil Bovespa | EWZ | 4.7% | -5.8% | 42.8% | 10% |
ENZY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.6% | -6.1% | 55.3% | -10% |
| Consumer Discretionary | XLY | -0.8% | -6.5% | 66.5% | -4% |
| Consumer Staples | XLP | 0.6% | -3.9% | 59.7% | 5% |
| Energy | XLE | -2.6% | -9.1% | 65.3% | 10% |
| Financial | XLF | 0.2% | -7.6% | 55.1% | -15% |
| Health Care | XLV | -1.3% | -4.9% | 68.8% | 18% |
| Industrial | XLI | -1.6% | -8.8% | 51.8% | -13% |
| Materials | XLB | -1.7% | -8.3% | 55.4% | 6% |
| Real Estate | XLRE | -0.2% | -3.4% | 59.4% | 2% |
| Technology | XLK | -0.7% | -10.8% | 54.5% | 4% |
| Utilities | XLU | -1.6% | -6.8% | 56.5% | -10% |
| Aerospace & Defense | XAR | -1.1% | -10.5% | 40.7% | -36% |
| Biotech | XBI | -4.4% | -7.6% | 68.4% | 20% |
| Homebuilder | XHB | -4.1% | -12.3% | 63.2% | 7% |
| Retail | XRT | -1.1% | -6.7% | 64.3% | 2% |
ENZY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1% | -9.25% | 73.8% | 19% |
| Natural Gas | UNG | 2.6% | 4.2% | 87.2% | 18% |
| Gold | GLD | -0.4% | -3.8% | 43.9% | -27% |
| Silver | SLV | -1.4% | -5.5% | 45% | -7% |
| Copper | CPER | -9.7% | -17.3% | 37.8% | -10% |
ENZY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.7% | -5.6% | 63.3% | 15% |
| iShares High Yield Corp. Bond | HYG | -0.4% | -5.2% | 62.2% | 3% |